Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects
Not Applicable
Recruiting
- Conditions
- Bipolar DisorderMajor Depressive Disorder
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Alcediag
- Target Recruit Count
- 450
- Registration Number
- NCT06507787
- Locations
- 🇫🇷
CH Erstein, Erstein, France
🇫🇷AP-HP Corentin Celton, Issy-les-Moulineaux, France
🇫🇷Etablissement Public de Santé Mentale (EPSM) 74, La Roche-sur-Foron, France
Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers
Completed
- Conditions
- Major Depressive DisorderBipolar Disorder
- First Posted Date
- 2022-11-03
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Alcediag
- Target Recruit Count
- 418
- Registration Number
- NCT05603819
- Locations
- 🇩🇰
The Capital Region of Denmark, Copenhagen, Denmark
🇫🇷GHU Paris Psychiatrie & Neurosciences, Paris, France
🇪🇸Parc Sanitari Sant Joan de Déu, Sant Boi De Llobregat, Barcelona, Spain
News
No news found